CLR | MET | CLR + MET | ||||
---|---|---|---|---|---|---|
Adjusted OR (95% CI) | p | Adjusted OR (95% CI) | p | Adjusted OR (95% CI) | p | |
Late period | 2.64 (1.5–4.6) | 0.001 | 1.21 (0.65–2.21) | 0.562 | 2.37 (1.31–4.28) | 0.004 |
Age | 1.04 (1.02–1.06) | < 0.001 | 1.05 (1.03–1.08) | < 0.001 | 1.06 (1.03–1.08) | < 0.001 |
Male | 1.37 (0.75–2.51) | 0.336 | 1.37 (0.72–2.61) | 0.336 | 1.16 (0.64–2.09) | 0.627 |
DM | 1.25 (0.43–3.58) | 0.682 | 4.41 (1.09–17.82) | 0.037 | 2.1 (0.76–5.8) | 0.152 |
IHD | 1.37 (0.25–7.48) | 0.717 | 1.41 (0.16–12.68) | 0.758 | 1.08 (0.23–4.97) | 0.925 |
CHF | 0.18 (0.02–1.82) | 0.146 | 0.19 (0.01–2.78) | 0.222 | 1.04 (0.14–7.91) | 0.967 |
Previously treated | 1.35 (0.65–2.82) | 0.420 | 1.13 (0.5–2.55) | 0.776 | 1.2 (0.58–2.46) | 0.624 |